Microread
Company

Last deal

Amount

Series C

Stage

30.12.2020

Date

3

all rounds

$1.9M

Total amount

General

About Company
Microread is a company that develops detection reagents for gene testing.

Industry

Sector :

Subsector :

Keywords :

Also Known As

北京阅微基因技术股份有限公司, 阅微基因, Yueweijiyin, 苏州阅微基因技术有限公司

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Microread Genetics Co., Ltd., founded in 2009, is dedicated to commercializing genetic detection technology, with a particular focus on sequencing technology platforms. By employing refined production processes and quality verification, the company has successfully created a range of accurate, fast, simple, and cost-effective test reagents for forensic, clinical, agricultural, animal husbandry, and research applications. What sets Microread apart is its ability to operate in multiple fields simultaneously, including forensic, clinical, and scientific research, making it a unique player in the industry.